| Overview |
| bs-2543R-Cy3 |
| CLEC1B Polyclonal Antibody, Cy3 Conjugated |
| FCM |
| Human |
| Mouse, Rat, Cow |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CLEC1B |
| 1-100/329 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 51266 |
| Q9P126 |
| Cell membrane |
| CLEC2; CLEC2B; PRO1384; QDED721; 1810061I13Rik; C-type lectin domain family 1 member B; C-type lectin-like receptor 2; CLEC-2; CLEC1B; UNQ721/PRO1384 |
| Natural killer (NK) cells express multiple C-type (calcium-dependent) lectin-like receptors, that interact with major histocompatibility complex class I molecules and either inhibit or activate cytotoxicity and cytokine secretion. CLEC1B (also known as CLEC-2) is a C-type lectin-like receptor expressed in myeloid cells and NK cells. |
| Application Dilution |
| FCM |
1:20-100 |
Powered by Bioz